首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Application of a PEG precipitation method for solubility screening: A tool for developing high protein concentration formulations
【2h】

Application of a PEG precipitation method for solubility screening: A tool for developing high protein concentration formulations

机译:PEG沉淀法在溶解度筛选中的应用:开发高蛋白浓度制剂的工具

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous publications demonstrated that the extrapolated solubility by polyethylene glycol (PEG) precipitation method (Middaugh et al., J Biol Chem 1979; 254:367–370; Juckes, Biochim Biophys Acta 1971; 229:535–546; Foster et al., Biochim Biophys Acta 1973; 317:505; Mahadevan and Hall, AIChE J 1990; 36:1517–1528; Stevenson and Hageman, Pharm Res 1995; 12:1671–1676) has a strong correlation to experimentally measured solubility of proteins. Here, we explored the utility of extrapolated solubility as a method to compare multiple protein drug candidates when nonideality of a highly soluble protein prohibits accurate quantitative solubility prediction. To achieve high efficiency and reduce the amount of protein required, the method is miniaturized to microwell plate format for high-throughput screening application. In this simplified version of the method, comparative solubility of proteins can be obtained without the need of concentration measurement of the supernatant following the precipitation step in the conventional method. The monoclonal antibodies with the lowest apparent solubilities determined by this method are the most difficult to be concentrated, indicating a good correlation between the prediction and empirical observations. This study also shows that the PEG precipitation method gives results for opalescence prediction that favorably compares to experimentally determined opalescence levels at high concentration. This approach may be useful in detecting proteins with potential solubility and opalescence problems prior to the time-consuming and expensive development process of high concentration formulation.
机译:先前的出版物证明了通过聚乙二醇(PEG)沉淀法推断的溶解度(Middaugh等,生物化学杂志1979; 254:367-370; Juckes,Biochim Biophys Acta 1971; 229:535-546; Foster等人, Biochim Biophys Acta 1973; 317:505; Mahadevan and Hall,AIChE J 1990; 36:1517-1528; Stevenson and Hageman,Pharm Res 1995; 12:1671-1676)与实验测量的蛋白质溶解度密切相关。在这里,我们探讨了当高可溶性蛋白质的非理想性妨碍准确的定量溶解度预测时,外推溶解度作为比较多种蛋白质药物候选物的方法的实用性。为了实现高效率并减少所需的蛋白质量,该方法被小型化为微孔板格式,用于高通量筛选应用。在该方法的这种简化形式中,可以在常规方法中的沉淀步骤之后无需测量上清液的浓度即可获得比较的蛋白质溶解度。用这种方法测定的具有最低表观溶解度的单克隆抗体最难浓缩,表明预测和经验观察之间有良好的相关性。这项研究还表明,PEG沉淀法给出的乳光预测结果可与实验确定的高浓度乳光水平进行比较。该方法在耗时且昂贵的高浓度制剂开发过程之前,可用于检测具有潜在溶解性和乳光问题的蛋白质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号